|
|
|
Volumn 17, Issue 5, 2004, Pages 335-338
|
|
Chemokines and Drug Discovery
a a a
a
SMR Committee
*
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA;
4 [3 [4 (3,4 DICHLOROBENZYL) 2 MORPHOLINYLMETHYL]UREIDOMETHYL]BENZAMIDE;
CHEMOKINE;
CHEMOKINE RECEPTOR;
CHEMOKINE RECEPTOR CCR1;
CHEMOKINE RECEPTOR CXCR2 ANTAGONIST;
CYCLOSPORIN A;
MARAVIROC;
RECEPTOR BLOCKING AGENT;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG RESEARCH;
DRUG STRUCTURE;
IC 50;
MEDICAL SOCIETY;
UNITED KINGDOM;
ANIMALS;
CHEMOKINES;
DRUG DESIGN;
HUMANS;
RECEPTORS, CHEMOKINE;
|
|
EID: 4043154251
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (0)
|